Bluejay Diagnostics, Inc. (BJDX)
Nasdaq: BJDX · Surgical & Medical Instruments & Apparatus · Acton, MA · filing with the SEC since 2017
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 6, 2026 | Mar 31, 2025 | Mar 28, 2024 | Mar 20, 2023 | Mar 10, 2022 | · |
| Revenue | · | · | · | 249,040 | · | · |
| For lenders | ||||||
| Net interest income | · | · | · | · | -367,459 | -26,997 |
| Cost of revenue | · | · | · | 200,129 | · | · |
| Gross profit | · | · | · | 48,911 | · | · |
| Research and development | 3,046,448 | 3,471,671 | 5,714,574 | 4,152,152 | 1,147,955 | 527,253 |
| Selling, general and administrative | · | · | 283,443 | 451,421 | · | · |
| Sales and marketing | · | 8,297 | 283,443 | 451,421 | 289,726 | 73,022 |
| General and administrative | 3,906,524 | 3,689,648 | 4,313,200 | 4,763,114 | 1,792,482 | 596,116 |
| Total operating expenses | 6,952,972 | 7,169,616 | 10,311,217 | 9,366,687 | 3,230,163 | 1,196,391 |
| Operating income | -6,952,972 | -7,169,616 | -10,311,217 | -9,317,776 | -3,230,163 | -1,196,391 |
| Interest expense | 839 | 823,028 | · | · | 6,360 | 59,274 |
| Interest and investment income | 97,559 | 145,823 | 164,900 | 89,673 | · | · |
| Other income (expense), net | 7,769 | 129,027 | 192,429 | 168,464 | · | · |
| Total non-operating income (expense) | 104,489 | -548,178 | 357,329 | 20,828 | -258,135 | 38,106 |
| Net income including non-controlling interests | · | · | · | · | -3,488,298 | -1,158,285 |
| Net income | -6,848,483 | -7,717,794 | -9,953,888 | -9,296,948 | -3,488,298 | -1,158,285 |
| Net income to common shareholders | -6,848,483 | -20,940,847 | -9,953,888 | · | · | · |
| Earnings per share, basic | -15.25 | -456.75r | -14,525.92rb | -14,752.00rb | -13,120.00b | · |
| Earnings per share, diluted | -15.25 | -456.75r | -14,525.92rb | -14,752.00rb | -13,120.00b | · |
| Earnings per share, basic and diluted | · | · | · | · | -13,120.00b | -11,840.00b |
| Weighted average shares, basic | 449,043 | 45,848r | 685rb | 630rb | 266b | · |
| Weighted average shares, diluted | 449,043 | 45,848r | 685rb | 630rb | 266b | · |
| Weighted average shares, basic and diluted | · | · | · | · | 266b | 98b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-4 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseDebtInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOtherOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted